 |
Articles: Drug/Product Alerts |
Medtronic Announces FDA Approval of Two Deep Brain Stimulation Devices That Offer Programming Advances and New Tools for Patients with Movement Disorders
Medtronic, 05/22/09
Free full text
Taro Receives FDA Approval for Sulfacetamide Sodium Topical Suspension ANDA
Taro Pharmaceuticals USA, 05/22/09
Free full text
Avigen Granted AV411 Patent for Neuropathic Pain
Avigen, 05/21/09
Free full text
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
BayNews International, 05/21/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/21/09
Free full text
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Onyx Pharmaceuticals, 05/21/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/20/09
Free full text
Genentech and Biogen Idec Submit Applications to the FDA for Rituxan for Most Common Type of Adult Leukemia
Genentech, 05/20/09
Free full text
Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome
Medtronic, 05/20/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/19/09
Free full text
DA Grants Approval for Use of RISPERDAL CONSTA as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Janssen, 05/19/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/18/09
Free full text
Abbott Adds Hepatitis B Test to its Broad Menu of Immunoassays on the ARCHITECT i 2000 and i 2000SR
Abbott, 05/15/09 Lonza and Teva Announce Receipt of Regulatory Approval
Teva Pharmaceutical Industries, 05/15/09
Free full text
Teva Announces Approval And Launch Of Generic Urso 250 And Urso Forte
Teva Pharmaceutical Industries, 05/15/09
Free full text
Genentech to Present Advances With Targeted Cancer Medicines at ASCO
Genentech, 05/15/09
Free full text
Medtronic Demonstrates Positive Results on First Pacemaker Designed for Use with MRI
Medtronic, 05/15/09
Free full text
Novartis receives approval from FDA to market Prevacid 24HR as first and only OTC proton pump inhibitor in original prescription formulation
Novartis, 05/15/09
Free full text
UCB"s Cimzia Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology--
Enzon Pharmaceuticals, 05/15/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/14/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
142 Available Pages
|
|
